Hip & pelvis

The Korean Hip Society (대한고관절학회)
권호 표지
DOI QR코드

DOI QR Code

Deep Vein Thrombosis Prophylaxis after Total Hip Arthroplasty in Asian Patients

  • Kim, Jun-Shik (The Joint Replacement Center, Ewha Womans University Medical Center)
  • Received : 2018.05.22
  • Accepted : 2018.07.18
  • Published : 2018.12.01
⟨ Previous Next ⟩

Abstract

In Western patient populations, the reported incidence of imaging-demonstrated deep vein thrombosis (DVT) after total hip arthroplasty (THA) is as high as 70% without prophylaxis. The reported rates of symptomatic pulmonary embolism (PE) after THA in recent studies range from 0.6% to 1.5%, and the risk of fatal PE ranges from 0.11% to 0.19% in the absence of prophylaxis. Predisposing factors to DVT in western patients include advanced age, previous venous insufficiency, osteoarthritis, obesity, hyperlipidemia, dietary and genetic factors. However, Asian patients who have undergone THA have a strikingly low prevalence of DVT and virtually no postoperative PE. Some authors suggest low clinical prothrombotic risk factors and the absence of some DVT-related genetic factors in Asian patient populations decrease the risk of DVT, PE or both. In Korea, the prevalence of DVT after THA without thromboprophylaxis have ranges from 6.8% to 43.8%, and asymptomatic PE have ranges from 0% to 12.9%; there have been only two reported cases of fatal PE. Deep-wound infections resulting from postoperative hematomas or prolonged wound drainage have been reported with routine thromboprophylaxis. The prevalence of DVT differs varies based on patient ethnicity. Guidelines for the use of thromboprophylaxis were altered and focus on the potential value of outcomes compared with possible complications (e.g., bleeding).

Keywords

References

  1. Morris GK, Henry AP, Preston BJ. Prevention of deep-vein thrombosis by low-dose heparin in patients undergoing total hip replacement. Lancet. 1974;2:797-800.
  2. Fender D, Harper WM, Thompson JR, Gregg PJ. Mortality and fatal pulmonary embolism after primary total hip replacement. Results from a regional hip register. J Bone Joint Surg Br. 1997;79:896-9. https://doi.org/10.1302/0301-620X.79B6.0790896
  3. Pellegrini VD Jr, Clement D, Lush-Ehmann C, Keller GS, Evarts CM. The John Charnley Award. Natural history of thromboembolic disease after total hip arthroplasty. Clin Orthop Relat Res. 1996;(333):27-40.
  4. Park YS. Guideline for the prophylaxis of venous thromboembolism in hip surgery patients. J Korean Orthop Assoc. 2011;46:95-8. https://doi.org/10.4055/jkoa.2011.46.2.95
  5. Westrich GH, Weksler BB, Glueck CJ, Blumenthal BF, Salvati EA. Correlation of thrombophilia and hypofibrinolysis with pulmonary embolism following total hip arthroplasty: an analysis of genetic factors. J Bone Joint Surg Am. 2002;84-A:2161-7.
  6. Zivelin A, Rosenberg N, Faier S, et al. A single genetic origin for the common prothrombotic G20210A polymorphism in the prothrombin gene. Blood. 1998;92:1119-24. https://doi.org/10.1182/blood.V92.4.1119
  7. Kim YH, Oh SH, Kim JS. Incidence and natural history of deep-vein thrombosis after total hip arthroplasty. A prospective and randomised clinical study. J Bone Joint Surg Br. 2003;85:661-5.
  8. Kang BJ, Lee YK, Kim HJ, Ha YC, Koo KH. Deep venous thrombosis and pulmonary embolism are uncommon in East Asian patients after total hip arthroplasty. Clin Orthop Relat Res. 2011;469:3423-8. https://doi.org/10.1007/s11999-011-1979-7
  9. Klatsky AL, Armstrong MA, Poggi J. Risk of pulmonary embolism and/or deep venous thrombosis in Asian-Americans. Am J Cardiol. 2000;85:1334-7. https://doi.org/10.1016/S0002-9149(00)00766-9
  10. Nandi P, Wong KP, Wei WI, Ngan H, Ong GB. Incidence of postoperative deep vein thrombosis in Hong Kong Chinese. Br J Surg. 1980;67:251-3. https://doi.org/10.1002/bjs.1800670407
  11. Kim YH, Kim JS. The 2007 John Charnley Award. Factors leading to low prevalence of DVT and pulmonary embolism after THA: analysis of genetic and prothrombotic factors. Clin Orthop Relat Res. 2007;465:33-9.
  12. Hwang DS, Kwon ST, Yune SH, Hong RO, Lee SY. Deep venoud thrombosis after hip arthroplasty. J Korean Orthop Assoc. 1997;32:554-64. https://doi.org/10.4055/jkoa.1997.32.3.554
  13. Yoo MC, Cho YJ, Yim CM, Hong GP, Kim JM. Deep vein thrombosis and pulmonary embolism after cementless total hip arthroplasty. J Korean Orthop Assoc. 1998;33:1672-80. https://doi.org/10.4055/jkoa.1998.33.7.1672
  14. Evarts CM, Feil EJ. Prevention of thromboembolic disease after elective surgery of the hip. J Bone Joint Surg Am. 1971;53:1271-80. https://doi.org/10.2106/00004623-197153070-00002
  15. Paiement GD, Wessinger SJ, Hughes R, Harris WH. Routine use of adjusted low-dose warfarin to prevent venous thromboembolism after total hip replacement. J Bone Joint Surg Am. 1993;75:893-8. https://doi.org/10.2106/00004623-199306000-00010
  16. Thromboembolic Risk Factors (THRIFT) Consensus Group. Risk of and prophylaxis for venous thromboembolism in hospital patients. BMJ. 1992;305:567-74. https://doi.org/10.1136/bmj.305.6853.567
  17. Johnson R, Green JR, Charnley J. Pulmonary embolism and its prophylaxis following the Charnley total hip replacement. Clin Orthop Relat Res. 1977;(127):123-32.
  18. Freedman KB, Brookenthal KR, Fitzgerald RH Jr, Williams S, Lonner JH. A meta-analysis of thromboembolic prophylaxis following elective total hip arthroplasty. J Bone Joint Surg Am. 2000;82-A:929-38.
  19. Murray DW, Britton AR, Bulstrode CJ. Thromboprophylaxis and death after total hip replacement. J Bone Joint Surg Br. 1996;78:863-70.
  20. Geerts WH, Bergqvist D, Pineo GF, et al. Prevention of venous thromboembolism: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest. 2008;133(6 Suppl):381S-453S. https://doi.org/10.1378/chest.08-0656
  21. Chau KY, Yuen ST, Wong MP. Clinicopathological pattern of pulmonary thromboembolism in Chinese autopsy patients: comparison with Caucasian series. Pathology. 1997;29:263-6. https://doi.org/10.1080/00313029700169035
  22. Chumnijarakij T, Poshyachinda V. Postoperative thrombosis in Thai women. Lancet. 1975;1:1357-8.
  23. Tso SC, Wong V, Chan V, Chan TK, Ma HK, Todd D. Deep vein thrombosis and changes in coagulation and fibrinolysis after gynaecological operations in Chinese: the effect of oral contraceptives and malignant disease. Br J Haematol. 1980;46:603-12. https://doi.org/10.1111/j.1365-2141.1980.tb06018.x
  24. Wahlander K, Larson G, Lindahl TL, et al. Factor V Leiden (G1691A) and prothrombin gene G20210A mutations as potential risk factors for venous thromboembolism after total hip or total knee replacement surgery. Thromb Haemost. 2002;87:580-5. https://doi.org/10.1055/s-0037-1613052
  25. Woo KS, Tse LK, Tse CY, Metreweli C, Vallance-Owen J. The prevalence and pattern of pulmonary thromboembolism in the Chinese in Hong Kong. Int J Cardiol. 1988;20:373-80. https://doi.org/10.1016/0167-5273(88)90291-4
  26. Balasa VV, Gruppo RA, Glueck CJ, et al. The relationship of mutations in the MTHFR, prothrombin, and PAI-1 genes to plasma levels of homocysteine, prothrombin, and PAI-1 in children and adults. Thromb Haemost. 1999;81:739-44. https://doi.org/10.1055/s-0037-1614564
  27. Levine MN, Raskob G, Beyth RJ, Kearon C, Schulman S. Hemorrhagic complications of anticoagulant treatment: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest. 2004;126(3 Suppl):287S-310S. https://doi.org/10.1378/chest.126.3_suppl.287S
  28. Salvati EA, Della Valle AG, Westrich GH, et al. The John Charnley Award: heritable thrombophilia and development of thromboembolic disease after total hip arthroplasty. Clin Orthop Relat Res. 2005;441:40-55. https://doi.org/10.1097/01.blo.0000192366.61616.81
  29. Parvizi J, Ghanem E, Joshi A, Sharkey PF, Hozack WJ, Rothman RH. Does "excessive" anticoagulation predispose to periprosthetic infection? J Arthroplasty. 2007;22(6 Suppl 2):24-8. https://doi.org/10.1016/j.arth.2007.03.007
  30. Parvizi J, Kahl LK, Dalsey C. Aggressive anticoagulation after TJA: an evaluation of the ACCP guidelines for thromboprophylaxis. J Long Term Eff Med Implants. 2007;17:359-65. https://doi.org/10.1615/JLongTermEffMedImplants.v17.i4.90
  31. Colwell CW Jr. Rationale for thromboprophylaxis in lower joint arthroplasty. Am J Orthop (Belle Mead NJ). 2007;36(9 Suppl):11-3.
  32. Fitzgerald RH Jr. Controversies in the prevention of deep vein thrombosis with total hip arthroplasty. Orthopedics. 1994;17 Suppl:8-10.
  33. Patel VP, Walsh M, Sehgal B, Preston C, DeWal H, Di Cesare PE. Factors associated with prolonged wound drainage after primary total hip and knee arthroplasty. J Bone Joint Surg Am. 2007;89:33-8. https://doi.org/10.2106/JBJS.F.00163
  34. Falck-Ytter Y, Francis CW, Johanson NA, et al. Prevention of VTE in orthopedic surgery patients: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest. 2012;141(2 Suppl):e278S-325S. https://doi.org/10.1378/chest.11-2404
  35. Callaghan JJ, Dorr LD, Engh GA, et al. Prophylaxis for thromboembolic disease: recommendations from the American College of Chest Physicians--are they appropriate for orthopaedic surgery? J Arthroplasty. 2005;20:273-4. https://doi.org/10.1016/j.arth.2005.01.014
  36. Lieberman JR, Heckmann N. Venous thromboembolism prophylaxis in total hip arthroplasty and total knee arthroplasty patients: from guidelines to practice. J Am Acad Orthop Surg. 2017;25:789-98. https://doi.org/10.5435/JAAOS-D-15-00760

Cited by

  1. Is the Oral Chemical Prophylaxis Necessary for the Prevention of Venous Thromboembolism after Joint Arthroplasty in a Korean Population? vol.31, pp.3, 2018, https://doi.org/10.5371/hp.2019.31.3.150
  2. Impact of clinical pharmacist services on anticoagulation management of total joint arthroplasty: A retrospective observational study vol.46, pp.5, 2018, https://doi.org/10.1111/jcpt.13428